Tech Company Inital Public Offerings
Coherus BioSciences IPO
Coherus BioSciences, operating out of Redwood City, offered its shares in an initial public offering on 11/7/2014.
Transaction Overview
Company Name
Announced On
11/7/2014
Transaction Type
IPO
Amount
$85,050,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
333 Twin Dolphin Dr. 600
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Website
Email Address
Not Recorded
Overview
Coherus Biosciences is a leading developer of high-quality biosimilar therapeutics with a robust biosimilar pipeline aimed to improve biologic drugs access.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dennis Lanfear
Chief Financial Officer
Jean-Frederic Viret
Chief Medical Officer
Barbara Finck
Chief Technical Officer
Peter Watler
Executive Vice President
Vince Anicetti
Executive Vice President
Vladimir Vexler
VP - Bus. Development
Erik Wiberg
VP - Sales
Michael Fleming
Browse more venture capital transactions:
Prev: 11/7/2014: H2O venture capital transaction
Next: 11/7/2014: LumaStream venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs